SCHEMBL8941285

SCHEMBL8941285

CC(=O)OS(=O)(=O)Oc1c(C(C)C)cc(C(C)C)cc1C(C)C

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 2/20 0.46
FABP4 P15090 2/20 0.46
FABP5 Q01469 1/20 0.46
SOAT2 O75908 1/20 0.44
MYC P01106 1/20 0.44
SOAT1 P35610 1/20 0.44
MAP2K3 P46734 1/20 0.44
RARG P13631 2/20 0.37
RXRA P19793 2/20 0.37
PPARG P37231 2/20 0.37
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8941158 0.82
SCHEMBL14015388 0.78 FABP4 (0.58) FABP3FABP4FABP5SOAT2MYC
SCHEMBL2456678 0.75 FABP4 (0.50) FABP3FABP4FABP5SOAT2MYC
SCHEMBL8176820 0.75 FABP3 (0.52) FABP3FABP4FABP5SOAT2MYC
SCHEMBL17179591 0.75 FABP4 (0.55) FABP3FABP4FABP5SOAT2MYC
SCHEMBL8495954 0.74 FABP4 (0.48) FABP3FABP4FABP5SOAT2MYC
SCHEMBL17133806 0.74 FABP4 (0.48) FABP3FABP4FABP5SOAT2MYC
SCHEMBL8941282 0.73 SOAT2 (0.46) FABP3FABP4FABP5SOAT2MYC
SCHEMBL14431576 0.69 FABP4 (0.51) FABP3FABP4FABP5SOAT2MYC
SCHEMBL15294567 0.69 FABP4 (0.47) FABP3FABP4FABP5SOAT2MYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996019444-A1 SULFONATE ACAT INHIBITORS WARNER-LAMBERT COMPANY (US) 1996-06-27 WO disclosed
US-5510379-A USEFUL FOR TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-04-23 US disclosed